Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay

Analytical Biochemistry

Volumn 427, Issue 1, 2012, Pages 69-78

  Bozza, William P ^a   Yang, Kun ^a   Wang, Jialiang ^a   Zhuang, Zhihao ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Antagonist; DNA synthesis; Fluorescence assay; Multivalent binding; PCNA

Indexed keywords

ANTIGENS; CELL PROLIFERATION; CELLS; DIAGNOSIS; DISSOCIATION; DNA; FLUORESCENCE; PEPTIDES; POLARIZATION;

ANTAGONIST; DNA SYNTHESISS; FLUORESCENCE ASSAY; MULTIVALENT BINDING; PCNA;

CYTOLOGY;

CELL EXTRACT; CELL PROTEIN; COMPLEMENTARY DNA; CYCLINE; DEOXYRIBODIPYRIMIDINE PHOTOLYASE; GENOMIC DNA; PROLIFERATING CELL NUCLEAR ANTIGEN ANTAGONIST; PROTEIN INHIBITOR; PROTEIN P21; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL CYCLE REGULATION; CELL PROLIFERATION; CIRCULAR DICHROISM; CONTROLLED STUDY; DISSOCIATION CONSTANT; DNA REPLICATION; DNA SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; POLARIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION;

EID: 84861949244     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.04.018     Document Type: Article

References (47)

1. S.P. Bell, and A. Dutta DNA replication in eukaryotic cells Annu. Rev. Biochem. 71 2002 333 374
2. M. Laiho, and L. Latonen Cell cycle control, DNA damage checkpoints and cancer Ann. Med. 35 2003 391 397
3. G.L. Moldovan, B. Pfander, and S. Jentsch PCNA, the maestro of the replication fork Cell 129 2007 665 679
4. G. Maga, and U. Hubscher Proliferating cell nuclear antigen (PCNA): a dancer with many partners J. Cell Sci. 116 2003 3051 3060
5. Z. Zhuang, and Y. Ai Processivity factor of DNA polymerase and its expanding role in normal and translesion DNA synthesis Biochim. Biophys. Acta 2010 1804 1081 1093
6. S. Waga, G.J. Hannon, D. Beach, and B. Stillman The p21 inhibitor of cyclin-dependent kinases controls DNA-replication by interaction with PCNA Nature 369 1994 574 578
7. Z. Kelman, and J. Hurwitz Protein-PCNA interactions: a DNA-scanning mechanism? Trends Biochem. Sci. 23 1998 236 238
8. C. Sakakura, A. Hagiwara, H. Tsujimoto, K. Ozaki, T. Sakakibara, T. Oyama, M. Ogaki, and T. Takahashi Inhibition of gastric-cancer cell proliferation by antisense oligonucleotides targeting the messenger-RNA encoding proliferating cell nuclear antigen Br. J. Cancer 70 1994 1060 1066
9. M. Simons, E.R. Edelman, and R.D. Rosenberg Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model J. Clin. Invest. 93 1994 2351 2356
10. Y. Morita, N. Kashihara, M. Yamamura, H. Okamoto, S. Harada, Y. Maeshima, K. Okamoto, and H. Makino Inhibition of rheumatoid synovial fibroblast proliferation by antisense oligonucleotides targeting proliferating cell nuclear antigen messenger RNA Arthritis Rheum. 40 1997 1292 1297
11. K.A. Corsi, E.M. Schwarz, D.J. Mooney, and J. Huard Regenerative medicine in orthopaedic surgery J. Orthop. Res. 25 2007 1261 1268
12. J.M. Kelm, and M. Fussenegger Microscale tissue engineering using gravity-enforced cell assembly Trends Biotechnol. 22 2004 195 202
13. C. Fux, B. Mitta, B.P. Kramer, and M. Fussenegger Dual-regulated expression of C/EBP- and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts Nucleic Acids Res. 32 2004 e1
14. C. Indiani, and M. O'Donnell The replication clamp-loading machine at work in the three domains of life Nat. Rev. Mol. Cell. Biol. 7 2006 751 761
15. J.B. Bruning, and Y. Shamoo Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase- p66 subunit and flap endonuclease-1 Structure 12 2004 2209 2219
16. M. Peter, and I. Herskowitz Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle Cell 79 1994 181 184
17. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach P21 is a universal inhibitor of cyclin kinases Nature 366 1993 701 704
18. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
19. Y. Luo, J. Hurwitz, and J. Massague Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 Nature 375 1995 159 161
20. E. Warbrick, D.P. Lane, D.M. Glover, and L.S. Cox A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen Curr. Biol. 5 1995 275 282
21. D.I. Zheleva, N.Z. Zhelev, P.M. Fischer, S.V. Duff, E. Warbrick, D.G. Blake, and D.P. Lane A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics Biochemistry 39 2000 7388 7397
22. G. Kontopidis, S.Y. Wu, D.I. Zheleva, P. Taylor, C. McInnes, D.P. Lane, P.M. Fischer, and M.D. Walkinshaw Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design Proc. Natl. Acad. Sci. USA 102 2005 1871 1876
23. H. Xu, P. Zhang, L. Liu, and M.Y. Lee A novel PCNA-binding motif identified by the panning of a random peptide display library Biochemistry 40 2001 4512 4520
24. E. Warbrick A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening, and rational design Oncogene 25 2006 2850 2859
25. J.C. Sacchettini, L.G. Baum, and C.F. Brewer Multivalent protein-carbohydrate interactions: a new paradigm for supermolecular assembly and signal transduction Biochemistry 40 2001 3009 3015
26. T.K. Dam, and C.F. Brewer Multivalent lectin-carbohydrate interactions energetics and mechanisms of binding Adv. Carbohydr. Chem. Biochem. 63 2010 139 164
27. D. Deniaud, K. Julienne, and S.G. Gouin Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands Org. Biomol. Chem. 9 2011 966 979
28. F. Fang, and M. Yu Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196 J. Antimicrob. Chemother. 53 2004 23 25
29. J. Dernedde, A. Rausch, M. Weinhart, S. Enders, R. Tauber, K. Licha, M. Schirner, U. Zugel, A. von Bonin, and R. Haag Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation Proc. Natl. Acad. Sci. USA 107 2010 19679 19684
30. S.R. Banerjee, M. Pullambhatla, H. Shallal, A. Lisok, R.C. Mease, and M.G. Pomper A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA) Oncotarget 2 2011 1244 1253
31. B. Neron, H. Menager, C. Maufrais, N. Joly, J. Maupetit, S. Letort, S. Carrere, P. Tuffery, and C. Letondal Mobyle: a new full web bioinformatics framework Bioinformatics 25 2009 3005 3011
32. C.H. Kenny, W. Ding, K. Kelleher, S. Benard, E.G. Dushin, A.G. Sutherland, L. Mosyak, R. Kriz, and G. Ellestad Development of a fluorescence polarization assay to screen for inhibitors of the FtsZ/ZipA interaction Anal. Biochem. 323 2003 224 233
33. W.B. Dandliker, M.L. Hsu, J. Levin, and B.R. Rao Equilibrium and kinetic inhibition assays based upon fluorescence polarization Methods Enzymol. C 74 1981 3 28
34. J.J. Li, and T.J. Kelly Simian virus 40 DNA replication in vitro: specificity of initiation and evidence for bidirectional replication Mol. Cell. Biol. 5 1985 1238 1246
35. J.M. Gulbis, Z. Kelman, J. Hurwitz, M. O'Donnell, and J. Kuriyan Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA Cell 87 1996 297 306
36. V. Esteve, N. Canela, A. Rodriguez-Vilarrupla, R. Aligue, N. Agell, I. Mingarro, O. Bachs, and E. Perez-Paya The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition ChemBioChem 4 2003 863 869
37. U. Chen, S. Chen, P. Saha, and A. Dutta P21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex Proc. Natl. Acad. Sci. USA 93 1996 11597 11602
38. K.L. Ball, S. Lain, R. Fahraeus, C. Smythe, and D.P. Lane Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 Curr. Biol. 7 1997 71 80
39. C. Cayrol, M. Knibiehler, and B. Ducommun P21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells Oncogene 16 1998 311 320
40. G.L. Bidwell 3rd, and D. Raucher Cell penetrating elastin-like polypeptides for therapeutic peptide delivery Adv. Drug Deliv. Rev. 62 2010 1486 1496
41. M. Mutoh, F.D. Lung, Y.Q. Long, P.P. Roller, R.S. Sikorski, and P.M. O'Connor A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells Cancer Res. 59 1999 3480 3488
42. H. Mattock, D.P. Lane, and E. Warbrick Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein Exp. Cell Res. 265 2001 234 241
43. J.T. Heeres, and P.J. Hergenrother High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies Chem. Soc. Rev. 40 2011 4398 4410
44. T. Chen, N. Kablaoui, J. Little, S. Timofeevski, W.R. Tschantz, P. Chen, J. Feng, M. Charlton, R. Stanton, and P. Bauer Identification of small-molecule inhibitors of the JIP-JNK interaction Biochem. J. 420 2009 283 294
45. A. Fowler, D. Swift, E. Longman, A. Acornley, P. Hemsley, D. Murray, J. Unitt, I. Dale, E. Sullivan, and M. Coldwell An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases Anal. Biochem. 308 2002 223 231
46. A. Kiessling, B. Sperl, A. Hollis, D. Eick, and T. Berg Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules Chem. Biol. 13 2006 745 751
47. L.A. Arnold, E. Estebanez-Perpina, M. Togashi, N. Jouravel, A. Shelat, A.C. McReynolds, E. Mar, P. Nguyen, J.D. Baxter, R.J. Fletterick, P. Webb, and R.K. Guy Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators J. Biol. Chem. 280 2005 43048 43055